Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed, replacing v3.6.3. This indicates a new version of the page source rather than a change to study details or functionality.
    Difference
    0.0%
    Check dated 2026-07-25T23:14:24.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, reflecting a new version of the page.
    Difference
    0.0%
    Check dated 2026-07-04T13:19:53.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page.
    Difference
    0.0%
    Check dated 2026-06-27T06:03:54.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status note ('No longer looking for participants'), improving visibility and user flow. The Intervention header was updated from 'Intervention / Treatment' to 'Intervention/Treatment' and the page revision tag updated to v3.6.0, while the old label was removed.
    Difference
    0.4%
    Check dated 2026-06-13T00:20:23.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates an administrative update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-06-05T17:25:57.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    A new publication citation is added to the Publications section, reporting Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in PD-L1-unselected, metastatic NSCLC. The publication record is updated to Revision: v3.5.4, replacing the prior v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T06:14:21.000Z thumbnail image

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.